Meta is taking a significant step toward mainstream adoption of smart glasses, preparing to launch two new Ray-Ban models – codenamed Scriber and Blazer – designed specifically for prescription eyewear. Spotted in filings with the Federal Communications Commission, these glasses are expected to arrive for consumers as early as next week, according to a Bloomberg report. This isn’t about groundbreaking new hardware. it’s a strategic move to tap into a vastly larger market and fundamentally change how people buy and experience augmented reality.
Currently, prescription eyewear accounts for approximately 69 percent of the $223 billion global eyewear market. While Meta sold over seven million Ray-Ban and Oakley frames with AI capabilities in 2025 – an impressive number for a nascent product category – it represents a small fraction of the estimated 1.5 billion people worldwide who require vision correction. The launch of Scriber and Blazer signals Meta’s clearest attempt yet to move smart glasses beyond the realm of consumer electronics and into the established channels of optical retail, where scale, customer access, and profit margins are substantially greater.
The move comes as the smart glasses market is projected to grow rapidly, from an estimated $2.5 billion in 2025 to $14.4 billion by 2033, according to market research firm Grand View Research. However, this growth is contingent on convincing consumers to choose connected frames over traditional, cheaper, and lighter alternatives.
What Scriber and Blazer Offer – and Don’t
Scriber and Blazer are categorized as non-display AI glasses, meaning they lack the heads-up display found in other Meta smart glasses. They share core functionality with the existing Ray-Ban Meta line, including a camera, microphone, speakers, and integration with Meta AI. Blazer will be available in both regular and large sizes, while Scriber appears to be a single-size offering. Both models feature an upgrade to Wi-Fi 6 UNII-4 band support and will ship with charging cases.
This distinction is crucial. Meta already offers the Ray-Ban Meta Display, launched at Connect 2025, which boasts a full-color heads-up display, a 12-megapixel camera with 3x zoom, and compatibility with a neural wristband for gesture-based navigation. The Meta Display is priced at $799. Meta’s augmented reality prototype, Orion, with holographic displays, remains a research project with no confirmed consumer release date. Scriber and Blazer are positioned below these models in terms of technological sophistication, focusing instead on integrating Meta AI into eyewear that people already need to purchase.
As Mark Zuckerberg explained on a recent earnings call, “billions of people wear glasses or contacts for vision correction,” and he envisions a future “where most glasses that people wear aren’t AI glasses” within a few years. The logic is simple: the incremental cost of adding smart features to glasses someone is already planning to buy is significantly lower than selling a completely new device.
Navigating the Complex Partnership with EssilorLuxottica
This prescription-focused strategy directly intersects with Meta’s most complex business relationship: its partnership with EssilorLuxottica. The Franco-Italian conglomerate, which owns Ray-Ban, Oakley, LensCrafters, and Sunglass Hut, manufactures all of Meta’s smart glasses and controls the crucial optical retail distribution network. While the partnership has yielded results, it hasn’t been without friction.
Bloomberg reported in February that Meta and EssilorLuxottica were navigating disagreements regarding pricing and strategy. In 2025, EssilorLuxottica’s adjusted gross margin decreased by 2.6 percentage points to 60.9 percent, partially attributed to the higher component costs associated with smart glasses compared to traditional frames. Meta reportedly sought to offer discounts during Black Friday in 2023, a move EssilorLuxottica rejected to protect its luxury brand positioning. This tension stems from differing priorities: Meta aims to maximize adoption and integrate users into its AI ecosystem, while EssilorLuxottica prioritizes maintaining margins on its product lines.
Prescription models could potentially alleviate this tension. Prescription lenses command higher retail prices and margins than non-prescription sunglasses. The additional services associated with prescription orders – lens coatings, custom grinding, and fitting appointments – generate further revenue throughout the supply chain. If smart glasses gain traction within the prescription market, the economics could improve for EssilorLuxottica even as Meta increases sales volume. Reports suggest the companies are considering doubling their combined production target to 20 million units annually, up from an estimated capacity of 10 million by the complete of 2026.
Challenges and Risks in the Optical Retail Space
Selling smart glasses through optical retailers introduces unique challenges. Opticians are trained in vision care and lens fitting, not in explaining AI assistants, camera privacy settings, or software updates. The customer experience at a LensCrafters differs significantly from that of a Meta Store or Apple Store, and the training, support, and return handling required for a connected device are far more complex than for a standard pair of glasses.
Legal risks likewise loom. In January 2026, Solos Technology filed a patent infringement lawsuit against Meta and EssilorLuxottica, alleging that the Ray-Ban Meta line infringes on several patents related to core smart eyewear technologies and seeking “multiple billions of dollars” in damages. This legal challenge, combined with the existing partnership tensions and margin pressures, adds another layer of risk to a product line that Meta considers foundational to its wearable AI strategy.
Consumer privacy remains a key concern. While the smart glasses market is growing, its success hinges on overcoming consumer hesitation regarding data security and potential misuse of features like the integrated camera. Meta will need to clearly address these concerns to build trust and encourage widespread adoption.
Scriber and Blazer aren’t intended to be the definitive test of Meta’s smart glasses vision. They represent a strategic move to place Meta AI within the existing purchasing habits of billions of potential customers, leveraging the established infrastructure of optical retail. The technology itself is incremental, but the ambition behind it is not. The next key indicator will be observing how quickly these models are integrated into EssilorLuxottica’s retail channels and the initial consumer response to the combination of prescription eyewear and AI functionality.
What are your thoughts on the integration of AI into everyday eyewear? Share your comments below, and let us know if you’d consider purchasing smart glasses with your prescription.
